Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study.

Ballantyne CM, Hoogeveen RC, McNeill AM, Heiss G, Schmidt MI, Duncan BB, Pankow JS.

Int J Obes (Lond). 2008 May;32 Suppl 2:S21-4. doi: 10.1038/ijo.2008.31.

3.

The metabolic syndrome and cardiovascular risk in the British Regional Heart Study.

Wannamethee SG.

Int J Obes (Lond). 2008 May;32 Suppl 2:S25-9. doi: 10.1038/ijo.2008.32.

PMID:
18469839
4.

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study.

McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G.

Diabetes Care. 2005 Feb;28(2):385-90.

PMID:
15677797
5.

[Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes].

Gimeno Orna JA, Lou Arnal LM, Molinero Herguedas E, Boned Julián B, Portilla Córdoba DP.

Rev Esp Cardiol. 2004 Jun;57(6):507-13. Spanish.

6.

Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.

de Simone G, Devereux RB, Chinali M, Best LG, Lee ET, Galloway JM, Resnick HE; Strong Heart Study Investigators..

Diabetes Care. 2007 Jul;30(7):1851-6. Epub 2007 Apr 17.

PMID:
17440172
7.

The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study.

van Herpt TT, Dehghan A, van Hoek M, Ikram MA, Hofman A, Sijbrands EJ, Franco OH.

Cardiovasc Diabetol. 2016 Apr 27;15:69. doi: 10.1186/s12933-016-0387-4.

8.

Youth overweight and metabolic disturbances in predicting carotid intima-media thickness, type 2 diabetes, and metabolic syndrome in adulthood: the Cardiovascular Risk in Young Finns study.

Koskinen J, Magnussen CG, Sabin MA, Kähönen M, Hutri-Kähönen N, Laitinen T, Taittonen L, Jokinen E, Lehtimäki T, Viikari JS, Raitakari OT, Juonala M.

Diabetes Care. 2014 Jul;37(7):1870-7. doi: 10.2337/dc14-0008. Epub 2014 Apr 17.

PMID:
24742659
9.

Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies.

Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW, Lennon L, Macfarlane PW, Murphy MB, Packard CJ, Stott DJ, Westendorp RG, Whincup PH, Shepherd J, Wannamethee SG.

Lancet. 2008 Jun 7;371(9628):1927-35. doi: 10.1016/S0140-6736(08)60602-9. Epub 2008 May 22.

10.
11.

Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans.

Hwang YC, Jee JH, Oh EY, Choi YH, Lee MS, Kim KW, Lee MK.

Int J Cardiol. 2009 May 29;134(3):313-21. doi: 10.1016/j.ijcard.2008.12.025. Epub 2009 Jan 8.

PMID:
19131127
12.

Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol.

Gómez-Marcos MA, Recio-Rodríguez JI, Rodríguez-Sánchez E, Castaño-Sánchez Y, de Cabo-Laso A, Sánchez-Salgado B, Rodríguez-Martín C, Castaño-Sánchez C, Gómez-Sánchez L, García-Ortiz L.

BMC Public Health. 2010 Mar 18;10:143. doi: 10.1186/1471-2458-10-143.

13.

Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study.

Volcik KA, Ballantyne CM, Braun MC, Coresh J, Mosley TH, Boerwinkle E.

Am J Hypertens. 2008 May;21(5):533-8. doi: 10.1038/ajh.2007.81. Epub 2008 Feb 21.

14.

Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study.

Yang EY, Chambless L, Sharrett AR, Virani SS, Liu X, Tang Z, Boerwinkle E, Ballantyne CM, Nambi V.

Stroke. 2012 Jan;43(1):103-8. doi: 10.1161/STROKEAHA.111.626200. Epub 2011 Oct 27.

15.

Impact of blood pressure and other components of the metabolic syndrome on the development of cardiovascular disease.

Kang G, Guo L, Guo Z, Hu X, Wu M, Zhou Z, Zhou H, Liu S, Chen F.

Circ J. 2010 Mar;74(3):456-61. Epub 2010 Jan 7.

16.

Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile.

Choi HK, De Vera MA, Krishnan E.

Rheumatology (Oxford). 2008 Oct;47(10):1567-70. doi: 10.1093/rheumatology/ken305. Epub 2008 Aug 18.

PMID:
18710901
17.

Cardiometabolic risk: a Framingham perspective.

Wilson PW, Meigs JB.

Int J Obes (Lond). 2008 May;32 Suppl 2:S17-20. doi: 10.1038/ijo.2008.30. Review.

PMID:
18469835
18.

The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.

Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S; JPHC Study Group..

Hypertens Res. 2009 Apr;32(4):289-98. doi: 10.1038/hr.2009.14. Epub 2009 Feb 27.

PMID:
19262490
19.

Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.

Vlek AL, van der Graaf Y, Spiering W, Visseren FL; SMART study group..

J Hum Hypertens. 2008 May;22(5):358-65. doi: 10.1038/jhh.2008.5. Epub 2008 Feb 14.

PMID:
18273039
20.

A diagnosis of the metabolic syndrome in youth that resolves by adult life is associated with a normalization of high carotid intima-media thickness and type 2 diabetes mellitus risk: the Bogalusa heart and cardiovascular risk in young Finns studies.

Magnussen CG, Koskinen J, Juonala M, Chen W, Srinivasan SR, Sabin MA, Thomson R, Schmidt MD, Nguyen QM, Xu JH, Skilton MR, Kähönen M, Laitinen T, Taittonen L, Lehtimäki T, Rönnemaa T, Viikari JS, Berenson GS, Raitakari OT.

J Am Coll Cardiol. 2012 Oct 23;60(17):1631-9. doi: 10.1016/j.jacc.2012.05.056. Epub 2012 Sep 26.

Supplemental Content

Support Center